Kristen N Sieffert sold $16k of FOA
President at Finance of America Companies Inc.. 750 shares at an average of $21.09, traded Apr 1, 2025, filed Apr 3, 2025.
Score components
- +20RolePresident
- 0Trade size$16k at market
- 0Share of holdings soldSold 0.9% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.6%, 3m +9.5%, 6m +2.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001971552-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | MOption exercise Class A Common Stock10b5-1 | +5,428 | $0.00 | $0 | 56,403 | Apr 3, 2025 |
| Apr 1, 2025 | FTax withholding Class A Common Stock10b5-1 | -1,974 | $21.26 | $42k | 54,429 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Class A Common Stock10b5-1 | +13,441 | $0.00 | $0 | 67,870 | Apr 3, 2025 |
| Apr 1, 2025 | FTax withholding Class A Common Stock10b5-1 | -4,808 | $21.26 | $102k | 63,062 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Class A Common Stock10b5-1 | +41,666 | $0.00 | $0 | 104,728 | Apr 3, 2025 |
| Apr 1, 2025 | FTax withholding Class A Common Stock10b5-1 | -16,929 | $21.26 | $360k | 87,799 | Apr 3, 2025 |
| Apr 1, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -750 | $21.09 | $16k | 87,049 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -5,428 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -13,441 | $0.00 | $0 | 13,440 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -41,666 | $0.00 | $0 | 83,334 | Apr 3, 2025 |
| Apr 1, 2025 | AGrant or award Restricted Stock Unitsderivative10b5-1 | +88,088 | $0.00 | $0 | 88,088 | Apr 3, 2025 |
Related signals
Other insiders at Finance of America Companies Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | Finance of America Companies Inc. | Jeremy Prahm Chief Investment Officer | $79k 6,000 shares | -4% | |
| 8Weak | Finance of America Companies Inc. | Kristen N Sieffert President | $9,398 750 shares | -1% | |
| 12Weak | Finance of America Companies Inc. | Jeremy Prahm Chief Investment Officer | $84k 6,000 shares | -4% | |
| 13Weak | Finance of America Companies Inc. | Jeremy Prahm Chief Investment Officer | $101k 6,000 shares | -3% | |
| 8Weak | Finance of America Companies Inc. | Kristen N Sieffert President | $13k 750 shares | -1% | |
| 13Weak | Finance of America Companies Inc. | Jeremy Prahm Chief Investment Officer | $119k 6,000 shares | -3% | |
| 14Weak | Finance of America Companies Inc. | Jeremy Prahm Chief Investment Officer | $130k 6,000 shares | -3% | |
| 14Weak | Finance of America Companies Inc. | Jeremy Prahm Chief Investment Officer | $134k 6,000 shares | -3% | |
| 8Weak | Finance of America Companies Inc. | Kristen N Sieffert President | $18k 750 shares | -1% | |
| 14Weak | Finance of America Companies Inc. | Jeremy Prahm Chief Investment Officer | $154k 6,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.